Medication info
Exoneal Tablet 5/80/2.5 mg

Exoneal Tablet 5/80/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›80mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Light yellow oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202302824 · Approved 2023.09.25 · Insurance code 640007940

Summary

Main use
Treatment of essential hypertension and dyslipidemia (including hypercholesterolemia)
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. If possible, it is recommended that the dose be taken at the same time each day (e.g., before breakfast). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. For patients taking an amlodipine/valsartan combination and rosuvastatin as separate products, switching to this medicine (a combination product with the same amounts of each active ingredient) may be considered for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa) and mixed dyslipidemia (type IIb) Before and during treatment with rosuvastatin, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 mg once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to achieve control in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 mg once daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 2.5 or 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 2.5 or 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and dyslipidemia (including hypercholesterolemia)

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication is used for patients who need to take amlodipine/valsartan combination and rosuvastatin at the same time. The amlodipine/valsartan combination is used to treat hypertension, especially essential hypertension that is difficult to control with monotherapy. Rosuvastatin helps improve primary hypercholesterolemia and mixed dyslipidemia and is used as an adjunct when diet and exercise cannot control it. This medicine effectively manages blood pressure and blood cholesterol levels, thereby improving health.

How to take

Adult dose

Take 1 tablet once daily with water. If possible, it is recommended that the dose be taken at the same time each day (e.g., before breakfast). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. For patients taking an amlodipine/valsartan combination and rosuvastatin as separate products, switching to this medicine (a combination product with the same amounts of each active ingredient) may be considered for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa) and mixed dyslipidemia (type IIb) Before and during treatment with rosuvastatin, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 mg once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to achieve control in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 mg once daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 2.5 or 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 2.5 or 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with hypersensitivity to any of its components, in pregnant or breastfeeding women, or in patients with severe liver or kidney impairment. Patients with sodium or fluid depletion may experience hypotension, so their status should be checked before taking this medication, and blood pressure and symptoms should be closely monitored during use. It is important to frequently check potassium levels when used in patients with high potassium levels or in conjunction with medications that may increase potassium. It should be administered with caution to patients with impaired kidney function or those who have undergone kidney transplantation, and it should be discontinued immediately if allergic reactions such as angioedema occur. Patients with heart failure or after myocardial infarction should have their kidney function assessed regularly while taking this medication, and caution is warranted in patients with acute myocardial infarction. Elderly patients may be more sensitive to this medication, so starting at a lower dose and monitoring their condition is recommended. This medication can affect liver and kidney function, so regular blood tests and liver function tests are necessary. If symptoms like muscle pain, muscle weakness, fatigue, rash, dizziness, or sensory disturbances occur, consult a doctor immediately, especially since muscle-related symptoms can indicate serious side effects. This medication may interact with other drugs, so make sure to inform your doctor or pharmacist of any other medications you are taking. Caution is advised when driving or operating machinery as dizziness or fatigue may occur. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding mothers should also avoid it. This medication is not recommended for children and adolescents as safety and efficacy have not been established.

Side effects

Peripheral edema, heat sensation, increased ALT, increased AST, increased serum creatinine, flank pain, neck pain, dizziness, sensory loss, pharyngitis, rashes, nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, drowsiness, orthostatic dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, erythema, sweating, rash, itching, joint swelling, back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, local edema, facial edema, fatigue, flushing, weakness, facial flushing, chest pain, pain, nocturia, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, hypercholesterolemia, hypoglycemia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturia, gynecomastia, pain, malaise, weight loss, weight gain, decreased hemoglobin, decreased hematocrit, neutropenia, serum sickness, increased serum potassium, renal failure, kidney damage, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, vasculitis, vesicular dermatitis, myalgia, increased serum creatinine, pharyngitis, tonsillitis, spinal canal stenosis, aphasia, oral hemorrhage, vomiting, insulin-dependent diabetes, diabetic complications, leg fracture, spinal fracture, fracture, osteomyelitis, skin infection, dermatitis, skin mass, localized skin reaction, palpitations, second-degree atrioventricular block, angina exacerbation, auditory disturbance, vestibulitis, overactive bladder, increased serum creatinine, retinal detachment, vitreous detachment, skin tumor-like conditions, benign prostatic hyperplasia, herpes zoster, herniated disc, laceration, diplopia, thrombocytopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, immune thrombocytopenia, dyspepsia, facial edema, herpes zoster, vulvar pruritus, pruritus, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, itching, rash, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorder, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, severe muscle weakness, ocular muscle weakness, excessive peripheral vasodilation, reflex tachycardia, systemic hypotension, shock state, non-cardiogenic pulmonary edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and humidity, and it is safe to keep it at room temperature between 1 to 30 degrees Celsius. This is to maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Light yellow oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.